Loading…
Listeriosis in pediatric oncology patients
BACKGROUND Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published. METHODS The Memorial Sloan‐Kettering Cancer Cent...
Saved in:
Published in: | Cancer 1998-08, Vol.83 (4), p.817-820 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403 |
container_end_page | 820 |
container_issue | 4 |
container_start_page | 817 |
container_title | Cancer |
container_volume | 83 |
creator | Mora, Jaume White, Mary Dunkel, Ira J. |
description | BACKGROUND
Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published.
METHODS
The Memorial Sloan‐Kettering Cancer Center microbiology laboratory's database was searched for cases of Listeria monocytogenes infection during the period from January 1981 to December 1996, and thorough chart reviews of the cases identified in patients age < 21 years were performed.
RESULTS
Listerial infections occurred in 5 children (3 with leukemia, 1 with lymphoma, and 1 with a brain tumor) among 20,612 admissions to the pediatric department during this period. All five children were actively receiving therapy for their malignancy, and two also were receiving other potentially immunosuppressive therapies. None was receiving co‐trimoxazole prophylaxis. All were treated successfully for the Listeria monocytogenes infection with ampicillin and gentamicin (four patients) or ampicillin alone (one patient). At last follow‐up two patients were long term, event‐free survivors, two had died of their underlying malignancy, and one patient had died of cytomegalovirus pneumonitis.
CONCLUSIONS
Listeria monocytogenes infections in pediatric oncology patients can be treated successfully with ampicillin‐containing antibiotic regimens. Cancer 1998;83:817‐820. © 1998 American Cancer Society.
Listeria monocytogenes infections historically have been considered to be associated with a high mortality rate in adult cancer patients. This series, which to the authors' knowledge is the first in a pediatric oncology population, indicates that listeriosis may be treated successfully in children with cancer, confirming the better prognosis recently reported in adult oncology patients. |
doi_str_mv | 10.1002/(SICI)1097-0142(19980815)83:4<817::AID-CNCR28>3.0.CO;2-U |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73862799</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73862799</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403</originalsourceid><addsrcrecordid>eNqFkF2LEzEUhoO4rHXXnyD0QmRXmHoySSZJV8Rl1o9C2YJaWLw5pJkzEpnO1MkU6b93ho69UfAqnJz3vDw8jL3jMOMA6eurL4t8cc3B6gS4TK-4tQYMV9dGzOUbw_V8fru4S_L7_HNq3ooZzPLVTZqsH7HJ6egxmwCASZQUD0_Y0xh_9KNOlThn51aDsYpP2KtliB21oYkhTkM93VERXNcGP21q31TN98N057pAdRcv2VnpqkjPxveCrT-8_5p_Sparj4v8dpl4qa1JhPWyMEQEhdVGKqG4gpJMtilKocmBcIUshMq0E5x74pQpuzFGbYTnRoK4YC-Pvbu2-bmn2OE2RE9V5Wpq9hG1MFmqre2DD8egb5sYWypx14ataw_IAQeNiINGHIzgYAT_aEQjUGKvEbHXiEeNKBAwX2GK6776-ciw32ypOBWP3vr9i3HvondV2brah3iKpSLjoAfCb8fYr1DR4S-8_9L9E278Eb8BgryaUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73862799</pqid></control><display><type>article</type><title>Listeriosis in pediatric oncology patients</title><source>Wiley</source><source>EZB Free E-Journals</source><creator>Mora, Jaume ; White, Mary ; Dunkel, Ira J.</creator><creatorcontrib>Mora, Jaume ; White, Mary ; Dunkel, Ira J.</creatorcontrib><description>BACKGROUND
Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published.
METHODS
The Memorial Sloan‐Kettering Cancer Center microbiology laboratory's database was searched for cases of Listeria monocytogenes infection during the period from January 1981 to December 1996, and thorough chart reviews of the cases identified in patients age < 21 years were performed.
RESULTS
Listerial infections occurred in 5 children (3 with leukemia, 1 with lymphoma, and 1 with a brain tumor) among 20,612 admissions to the pediatric department during this period. All five children were actively receiving therapy for their malignancy, and two also were receiving other potentially immunosuppressive therapies. None was receiving co‐trimoxazole prophylaxis. All were treated successfully for the Listeria monocytogenes infection with ampicillin and gentamicin (four patients) or ampicillin alone (one patient). At last follow‐up two patients were long term, event‐free survivors, two had died of their underlying malignancy, and one patient had died of cytomegalovirus pneumonitis.
CONCLUSIONS
Listeria monocytogenes infections in pediatric oncology patients can be treated successfully with ampicillin‐containing antibiotic regimens. Cancer 1998;83:817‐820. © 1998 American Cancer Society.
Listeria monocytogenes infections historically have been considered to be associated with a high mortality rate in adult cancer patients. This series, which to the authors' knowledge is the first in a pediatric oncology population, indicates that listeriosis may be treated successfully in children with cancer, confirming the better prognosis recently reported in adult oncology patients.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/(SICI)1097-0142(19980815)83:4<817::AID-CNCR28>3.0.CO;2-U</identifier><identifier>PMID: 9708951</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Adolescent ; Adult ; ampicillin ; Ampicillin - therapeutic use ; Anti-Bacterial Agents - therapeutic use ; Biological and medical sciences ; Brain Neoplasms - microbiology ; Child ; Drug Therapy, Combination - therapeutic use ; Female ; gentamicin ; Gentamicins - therapeutic use ; Hematologic and hematopoietic diseases ; Humans ; leukemia ; Leukemia - microbiology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Listeria monocytogenes ; Listeriosis - drug therapy ; Listeriosis - etiology ; lymphoma ; Lymphoma, T-Cell - microbiology ; Male ; Medical sciences ; Neoplasms - microbiology ; oligodendroglioma ; pediatric oncology ; Penicillins - therapeutic use</subject><ispartof>Cancer, 1998-08, Vol.83 (4), p.817-820</ispartof><rights>Copyright © 1998 American Cancer Society</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2361079$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9708951$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mora, Jaume</creatorcontrib><creatorcontrib>White, Mary</creatorcontrib><creatorcontrib>Dunkel, Ira J.</creatorcontrib><title>Listeriosis in pediatric oncology patients</title><title>Cancer</title><addtitle>Cancer</addtitle><description>BACKGROUND
Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published.
METHODS
The Memorial Sloan‐Kettering Cancer Center microbiology laboratory's database was searched for cases of Listeria monocytogenes infection during the period from January 1981 to December 1996, and thorough chart reviews of the cases identified in patients age < 21 years were performed.
RESULTS
Listerial infections occurred in 5 children (3 with leukemia, 1 with lymphoma, and 1 with a brain tumor) among 20,612 admissions to the pediatric department during this period. All five children were actively receiving therapy for their malignancy, and two also were receiving other potentially immunosuppressive therapies. None was receiving co‐trimoxazole prophylaxis. All were treated successfully for the Listeria monocytogenes infection with ampicillin and gentamicin (four patients) or ampicillin alone (one patient). At last follow‐up two patients were long term, event‐free survivors, two had died of their underlying malignancy, and one patient had died of cytomegalovirus pneumonitis.
CONCLUSIONS
Listeria monocytogenes infections in pediatric oncology patients can be treated successfully with ampicillin‐containing antibiotic regimens. Cancer 1998;83:817‐820. © 1998 American Cancer Society.
Listeria monocytogenes infections historically have been considered to be associated with a high mortality rate in adult cancer patients. This series, which to the authors' knowledge is the first in a pediatric oncology population, indicates that listeriosis may be treated successfully in children with cancer, confirming the better prognosis recently reported in adult oncology patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>ampicillin</subject><subject>Ampicillin - therapeutic use</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Brain Neoplasms - microbiology</subject><subject>Child</subject><subject>Drug Therapy, Combination - therapeutic use</subject><subject>Female</subject><subject>gentamicin</subject><subject>Gentamicins - therapeutic use</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>leukemia</subject><subject>Leukemia - microbiology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Listeria monocytogenes</subject><subject>Listeriosis - drug therapy</subject><subject>Listeriosis - etiology</subject><subject>lymphoma</subject><subject>Lymphoma, T-Cell - microbiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neoplasms - microbiology</subject><subject>oligodendroglioma</subject><subject>pediatric oncology</subject><subject>Penicillins - therapeutic use</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkF2LEzEUhoO4rHXXnyD0QmRXmHoySSZJV8Rl1o9C2YJaWLw5pJkzEpnO1MkU6b93ho69UfAqnJz3vDw8jL3jMOMA6eurL4t8cc3B6gS4TK-4tQYMV9dGzOUbw_V8fru4S_L7_HNq3ooZzPLVTZqsH7HJ6egxmwCASZQUD0_Y0xh_9KNOlThn51aDsYpP2KtliB21oYkhTkM93VERXNcGP21q31TN98N057pAdRcv2VnpqkjPxveCrT-8_5p_Sparj4v8dpl4qa1JhPWyMEQEhdVGKqG4gpJMtilKocmBcIUshMq0E5x74pQpuzFGbYTnRoK4YC-Pvbu2-bmn2OE2RE9V5Wpq9hG1MFmqre2DD8egb5sYWypx14ataw_IAQeNiINGHIzgYAT_aEQjUGKvEbHXiEeNKBAwX2GK6776-ciw32ypOBWP3vr9i3HvondV2brah3iKpSLjoAfCb8fYr1DR4S-8_9L9E278Eb8BgryaUw</recordid><startdate>19980815</startdate><enddate>19980815</enddate><creator>Mora, Jaume</creator><creator>White, Mary</creator><creator>Dunkel, Ira J.</creator><general>John Wiley & Sons, Inc</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980815</creationdate><title>Listeriosis in pediatric oncology patients</title><author>Mora, Jaume ; White, Mary ; Dunkel, Ira J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>ampicillin</topic><topic>Ampicillin - therapeutic use</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Brain Neoplasms - microbiology</topic><topic>Child</topic><topic>Drug Therapy, Combination - therapeutic use</topic><topic>Female</topic><topic>gentamicin</topic><topic>Gentamicins - therapeutic use</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>leukemia</topic><topic>Leukemia - microbiology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Listeria monocytogenes</topic><topic>Listeriosis - drug therapy</topic><topic>Listeriosis - etiology</topic><topic>lymphoma</topic><topic>Lymphoma, T-Cell - microbiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neoplasms - microbiology</topic><topic>oligodendroglioma</topic><topic>pediatric oncology</topic><topic>Penicillins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mora, Jaume</creatorcontrib><creatorcontrib>White, Mary</creatorcontrib><creatorcontrib>Dunkel, Ira J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mora, Jaume</au><au>White, Mary</au><au>Dunkel, Ira J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Listeriosis in pediatric oncology patients</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1998-08-15</date><risdate>1998</risdate><volume>83</volume><issue>4</issue><spage>817</spage><epage>820</epage><pages>817-820</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>BACKGROUND
Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published.
METHODS
The Memorial Sloan‐Kettering Cancer Center microbiology laboratory's database was searched for cases of Listeria monocytogenes infection during the period from January 1981 to December 1996, and thorough chart reviews of the cases identified in patients age < 21 years were performed.
RESULTS
Listerial infections occurred in 5 children (3 with leukemia, 1 with lymphoma, and 1 with a brain tumor) among 20,612 admissions to the pediatric department during this period. All five children were actively receiving therapy for their malignancy, and two also were receiving other potentially immunosuppressive therapies. None was receiving co‐trimoxazole prophylaxis. All were treated successfully for the Listeria monocytogenes infection with ampicillin and gentamicin (four patients) or ampicillin alone (one patient). At last follow‐up two patients were long term, event‐free survivors, two had died of their underlying malignancy, and one patient had died of cytomegalovirus pneumonitis.
CONCLUSIONS
Listeria monocytogenes infections in pediatric oncology patients can be treated successfully with ampicillin‐containing antibiotic regimens. Cancer 1998;83:817‐820. © 1998 American Cancer Society.
Listeria monocytogenes infections historically have been considered to be associated with a high mortality rate in adult cancer patients. This series, which to the authors' knowledge is the first in a pediatric oncology population, indicates that listeriosis may be treated successfully in children with cancer, confirming the better prognosis recently reported in adult oncology patients.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>9708951</pmid><doi>10.1002/(SICI)1097-0142(19980815)83:4<817::AID-CNCR28>3.0.CO;2-U</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 1998-08, Vol.83 (4), p.817-820 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_proquest_miscellaneous_73862799 |
source | Wiley; EZB Free E-Journals |
subjects | Adolescent Adult ampicillin Ampicillin - therapeutic use Anti-Bacterial Agents - therapeutic use Biological and medical sciences Brain Neoplasms - microbiology Child Drug Therapy, Combination - therapeutic use Female gentamicin Gentamicins - therapeutic use Hematologic and hematopoietic diseases Humans leukemia Leukemia - microbiology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Listeria monocytogenes Listeriosis - drug therapy Listeriosis - etiology lymphoma Lymphoma, T-Cell - microbiology Male Medical sciences Neoplasms - microbiology oligodendroglioma pediatric oncology Penicillins - therapeutic use |
title | Listeriosis in pediatric oncology patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T02%3A19%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Listeriosis%20in%20pediatric%20oncology%20patients&rft.jtitle=Cancer&rft.au=Mora,%20Jaume&rft.date=1998-08-15&rft.volume=83&rft.issue=4&rft.spage=817&rft.epage=820&rft.pages=817-820&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/(SICI)1097-0142(19980815)83:4%3C817::AID-CNCR28%3E3.0.CO;2-U&rft_dat=%3Cproquest_cross%3E73862799%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73862799&rft_id=info:pmid/9708951&rfr_iscdi=true |